0.08
-1.30%
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Resonance Health
Its shares trade on ASX under the ticker RHT.AX. It has been listed since 23 October 1987. In the fiscal year to 30 June 2026, it reported revenue of A$15.8m and net income of A$1.5m. At that date it held total assets of A$18.7m and shareholders' equity of A$11.1m.
Resonance Health Ltd. operates as a healthcare company, which involves in the development and commercialization of technologies and services for the quantitative analysis of radiological images in a regulated and quality controlled environment. The company is headquartered in Perth, Western Australia. The firm's segments include Services, Research and Development, and Corporate. The firm's core product is FerriScan, which is a non-invasive liver diagnostic technology used for the measurement of iron in the liver. FerriScan is used for liver iron concentration (LIC) measurement from magnetic resonance imaging (MRI) scans of a patient's liver. The FerriScan analysis procedure produces a mean LIC measurement and a color coded map reflecting the iron distribution across the liver. The firm's product HepaFat-Scan, is a non-invasive method for measuring volumetric liver fat fraction (VLFF) from MRI scans. HepaFat-Scan is provided as an image analysis service. HepaFat-Scan is available for routine clinical use and for use in pharmaceutical company clinical trials.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 23 Oct 1987
- Employees
- 18
- Website
- resonancehealth.com ↗
Leadership
Pay as last reported
- Dr. Martin BlakeIndependent Non-Executive Chairman of the BoardA$59,999
- Mr. Andrew HarrisonChief Executive Officer
- Mr. Nick AllanChief Operating Officer, Chief Financial Officer & Joint Company SecretaryA$225,000
- Mr. Benjamin CarruthersChief Financial Officer
- Dr. Timothy St. PierreChief Research Scientist, since 2006A$67,119
- Mr. Mitchell WellsCompany Secretary, Non-Executive Director, since 2018A$260,000
- Mr. Simon PantonNon-Executive DirectorA$40,000
- Dr. Travis BaroniNon-Executive Independent DirectorA$40,000
- Mr. Aaron BrinkworthIndependent Non-Executive Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Advanced Technology: Resonance Health Ltd has developed cutting-edge technology in the field of medical imaging, allowing for accurate and non-invasive diagnosis.
- Strong Intellectual Property: The company possesses a robust portfolio of patents and intellectual property rights, providing a competitive advantage and potential revenue streams.
- Established Market Presence: Resonance Health Ltd has built a solid reputation and strong relationships with key stakeholders in the healthcare industry, including hospitals, clinics, and research institutions.
Weaknesses
- Limited Market Reach: Despite its achievements, Resonance Health Ltd still faces challenges in expanding its market reach, particularly in emerging markets where healthcare infrastructure may be underdeveloped.
- Reliance on Partnerships: The company relies heavily on strategic partnerships for distribution and marketing, which could potentially limit its control over pricing and market positioning.
- High Research and Development Costs: Developing and improving advanced medical imaging technology requires substantial investment, placing financial strain on Resonance Health Ltd.
Opportunities
- Growing Demand for Medical Imaging: The increasing global prevalence of chronic diseases and aging populations create a significant opportunity for Resonance Health Ltd to tap into the growing demand for accurate and efficient medical imaging solutions.
- Expansion into New Markets: By exploring partnerships or establishing subsidiaries in untapped markets, Resonance Health Ltd can diversify its revenue streams and expand its customer base.
- Technological Advancements: With ongoing advancements in technology, there is potential for Resonance Health Ltd to further enhance its imaging solutions, improving accuracy and efficiency.
Threats
- Intense Competitive Landscape: The medical imaging industry is highly competitive, with existing players and new entrants constantly striving to develop and market innovative solutions. Resonance Health Ltd must ensure it stays ahead of competitors.
- Regulatory and Compliance Challenges: Compliance with stringent regulatory requirements, such as obtaining necessary approvals and maintaining quality standards, poses challenges and potential delays for Resonance Health Ltd.
- Economic Volatility: Fluctuations in global economies and healthcare spending can impact the purchasing power of customers and healthcare providers, potentially affecting the demand for Resonance Health Ltd's products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.